Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Hottest Latest Alphabetical (A-Z) Alphabetical (Z-A)
Type:
All Topic Review Biography
Topic Review
CAR-T Cell Therapy in Pediatric Non-Hodgkin Lymphoma Treatment
Non-Hodgkin lymphomas (NHL) are a group of cancers that originate in the lymphatic system, especially from progenitor or mature B-cells, T-cells, or natural killer (NK) cells. NHL is the most common hematological malignancy worldwide and also the fourth most frequent type of cancer among pediatric patients. This cancer can occur in children of any age, but it is quite rare under the age of 5 years. In recent decades, available medicines and therapies have significantly improved the prognosis of patients with this cancer. However, some cases of NHL are treatment resistant. For this reason, immunotherapy, as a more targeted and personalized treatment strategy, is becoming increasingly important in the treatment of NHL in pediatric patients.
  • 172
  • 19 Dec 2023
Topic Review
Thoracentesis for the Management of Pleural Effusions
Pleural effusion refers to the accumulation of fluid in the pleural space, which can occur due to various underlying medical conditions. It is a relatively common finding, with approximately 1.5 million cases reported annually in the United States. Common causes include congestive heart failure, bacterial pneumonia, and malignancy. Thoracentesis, also known as needle thoracostomy or pleural tap, was first described by American physician Henry Ingersoll Bowditch in 1852 and involves the removal of excess pleural fluid for diagnostic and therapeutic purposes. It is often the preferred initial procedure for diagnosis and management of pleural effusions, with approximately 178,000 thoracenteses performed in the United States annually.
  • 342
  • 19 Dec 2023
Topic Review
RNA Combined with Nanoformulation to Advance Therapeutic Technologies
Nucleic acid-based therapies have the potential to address numerous diseases that pose significant challenges to more traditional methods. RNA-based therapies have emerged as a promising avenue, utilizing nanoformulation treatments to target a range of pathologies. Nanoformulation offers several advantages compared to other treatment modalities, including targeted delivery, low toxicity, and bioactivity suitable for drug loading. Various types of nanoformulations are available, such as liposomes, polymeric nanoparticles (NPs), magnetic NPs, nanoshells, and solid lipid nanoparticles (SLNs). RNA-based therapy utilizes intracellular gene nanoparticles with messenger RNA (mRNA) emerging prominently in cancer therapy and immunotechnology against infectious diseases. The approval of mRNA-based technology opens doors for future technological advancements, particularly self-amplifying replicon RNA (repRNA). RepRNA is a novel platform in gene therapy, comprising viral RNA with a unique molecular property that enables the amplification of all encoded genetic information countless times. As a result, repRNA-based therapies have achieved significant levels of gene expression.
  • 130
  • 19 Dec 2023
Topic Review
Wilms Tumor (Nephroblastoma)
Wilms tumor (or nephroblastoma) is a malignant and solid neoplasm that derives from the primitive renal bud. It represents the most frequent primary tumor of the urogenital tract in childhood, and treatment consists of surgery and chemo-radiotherapy. 
  • 223
  • 19 Dec 2023
Topic Review
Molecular Mechanisms Responsible for Altered Mitostasis in ALS
Amyotrophic lateral sclerosis (ALS) is a fatal multisystem disease characterized by progressive death of motor neurons, loss of muscle mass, and impaired energy metabolism. The morphology and dynamics of mitochondrial network, quality control mechanisms, motility, and overall mitochondrial function are closely interrelated pathways that play a fundamental role in the dyshomeostasis of mitochondria in neurons, surrounding glial cells, myocytes, and many other cell types across peripheral tissues. Molecular mechanisms responsible for altered mitostasis in ALS-affected cells contribute to excitotoxicity, oxidative stress, energy deficiency and, ultimately, the death of motoneurons and other cells. Damaged mitochondria can release a number of proapoptotic factors and inflammatory response activators called damage-related molecular patterns, which creates a cycle of direct communication between mitochondrial disorders, inflammation, and cell degeneration.
  • 300
  • 19 Dec 2023
Topic Review
Nutritional Factors Associated with Dental Caries
Nutrition and dietetic care span various life stages, addressing nutritional needs and exploring factors that shape dietary habits. Globally, an alarming disproportion in food resource distribution, coupled with substandard nutritional intake, underscores profound implications for oral health. 
  • 326
  • 18 Dec 2023
Topic Review
The History of HER2 Inhibitors
HER2 is highly expressed in a variety of malignant tumors and affects the prognosis of patients, making it a highly sensitive target for cancer therapy. Since the approval of the first HER2 inhibitor, trastuzumab, in 1998, HER2-targeted drugs have rapidly evolved. Currently, targeting HER2 drugs mainly include monoclonal antibodies (mAbs), tyrosine kinase inhibitors (TKIs), and antibody-drug conjugates (ADCs). 
  • 96
  • 18 Dec 2023
Topic Review
Nutrition in Pathogenesis of Uterine Fibroids
Uterine fibroids are common benign tumors in women. They pose significant public health concerns due to their prevalence and impact on women's quality of life. It's important to investigates various dietary components and their potential roles in the pathogenesis and symptomatology of uterine fibroids.
  • 241
  • 18 Dec 2023
Topic Review
Gene Therapy for Neovascular Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a complex and multifactorial disease and a leading cause of irreversible blindness in the elderly population. The anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the management and prognosis of neovascular AMD (nAMD) and is currently the standard of care for this disease. However, patients are required to receive repeated injections, imposing substantial social and economic burdens. The implementation of gene therapy methods to achieve sustained delivery of various therapeutic proteins holds the promise of a single treatment that could ameliorate the treatment challenges associated with chronic intravitreal therapy, and potentially improve visual outcomes. Several early-phase trials are currently underway, evaluating the safety and efficacy of gene therapy for nAMD; however, areas of controversy persist, including the therapeutic target, route of administration, and potential safety issues.
  • 414
  • 18 Dec 2023
Topic Review
Domestic Animal Models of Central Nervous System Tumors
Intracranial primary tumors (IPTs) are aggressive forms of malignancies that cause high mortality in both humans and domestic animals. Meningiomas are frequent adult IPTs in humans, dogs, and cats, and both benign and malignant forms cause a decrease in life quality and survival. Surgery is the primary therapeutic approach to treat meningiomas, but, in many cases, it is not resolutive. The chemotherapy and targeted therapy used to treat meningiomas also display low efficacy and many side effects. Therefore, it is essential to find novel pharmacological approaches to increase the spectrum of therapeutic options for meningiomas.
  • 577
  • 18 Dec 2023
  • Page
  • of
  • 1352
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
Video Production Service
Feedback